Geron Corp. (NASDAQ: GERN) on Monday, soared 3.94% from the previous trading day, before settling in for the closing price of $4.06. Within the past 52 weeks, GERN’s price has moved between $1.64 and $5.34.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 46.26% over the last five years. The company achieved an average annual earnings per share of -6.25%. With a float of $552.62 million, this company’s outstanding shares have now reached $602.80 million.
The firm has a total of 141 workers. Let’s measure their productivity. In terms of profitability, gross margin is -2113.26%, operating margin of -16559.94%, and the pretax margin is -15990.68%.
Geron Corp. (GERN) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Geron Corp. is 8.32%, while institutional ownership is 69.90%. The most recent insider transaction that took place on Jul 08 ’24, was worth 3,073,004. In this transaction EVP, Chief Operating Officer of this company sold 674,348 shares at a rate of $4.56, taking the stock ownership to the 0 shares. Before that another transaction happened on Jun 10 ’24, when Company’s EVP, Chief Medical Officer sold 287,900 for $4.63, making the entire transaction worth $1,334,129. This insider now owns 0 shares in total.
Geron Corp. (GERN) Earnings and Forecasts
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.08 earnings per share (EPS) for the period topping the consensus outlook (set at -0.1) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -6.25% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.00% during the next five years compared to -16.08% drop over the previous five years of trading.
Geron Corp. (NASDAQ: GERN) Trading Performance Indicators
Geron Corp. (GERN) is currently performing well based on its current performance indicators. A quick ratio of 3.60 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1856.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.36, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.12 in one year’s time.
Technical Analysis of Geron Corp. (GERN)
Analysing the last 5-days average volume posted by the [Geron Corp., GERN], we can find that recorded value of 6.64 million was lower than the volume posted last year of 10.45 million. As of the previous 9 days, the stock’s Stochastic %D was 56.19%. Additionally, its Average True Range was 0.19.
During the past 100 days, Geron Corp.’s (GERN) raw stochastic average was set at 25.58%, which indicates a significant decrease from 69.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 36.54% in the past 14 days, which was lower than the 55.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.37, while its 200-day Moving Average is $3.70. Now, the first resistance to watch is $4.29. This is followed by the second major resistance level at $4.35. The third major resistance level sits at $4.46. If the price goes on to break the first support level at $4.12, it is likely to go to the next support level at $4.01. Should the price break the second support level, the third support level stands at $3.95.
Geron Corp. (NASDAQ: GERN) Key Stats
Market capitalization of the company is 2.54 billion based on 593,133K outstanding shares. Right now, sales total 240 K and income totals -184,130 K. The company made 880 K in profit during its latest quarter, and -67,380 K in sales during its previous quarter.
